| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品零售流通(元) | 946,317,681.62 | 2,217,685,902.08 | 1,292,967,184.78 | 2,131,669,548.03 | 1,348,327,577.99 |
| 药品生产制造(元) | 634,568,732.19 | 1,505,095,898.47 | 697,297,313.14 | 1,998,672,475.47 | 919,493,685.30 |
| 其他(元) | 90,473,950.43 | 71,421,557.06 | - | 154,278,559.64 | - |
| 营业成本(元) | |||||
| 药品零售流通(元) | 846,929,565.28 | 2,010,930,241.60 | 1,177,228,992.54 | 1,887,856,662.87 | 1,214,330,182.11 |
| 药品生产制造(元) | 376,041,296.10 | 1,025,258,025.05 | 419,654,831.09 | 1,272,846,863.10 | 524,599,323.14 |
| 其他(元) | 74,368,785.68 | 65,741,031.45 | - | 191,439,269.08 | - |
| 毛利(元) | |||||
| 药品零售流通(元) | 99,388,116.34 | 206,755,660.48 | 115,738,192.24 | 243,812,885.16 | 133,997,395.88 |
| 药品生产制造(元) | 258,527,436.09 | 479,837,873.42 | 277,642,482.05 | 725,825,612.37 | 394,894,362.16 |
| 其他(元) | 16,105,164.75 | 5,680,525.61 | - | -37,160,709.44 | - |
| 毛利率(%) | |||||
| 药品零售流通(%) | 10.50 | 9.32 | 8.95 | 11.44 | 9.94 |
| 药品生产制造(%) | 40.74 | 31.88 | 39.82 | 36.32 | 42.95 |
| 其他(%) | 17.80 | 7.95 | - | -24.09 | - |
| 收入构成(%) | |||||
| 药品零售流通(%) | 56.62 | 58.45 | 64.96 | 49.75 | 59.45 |
| 药品生产制造(%) | 37.97 | 39.67 | 35.04 | 46.65 | 40.55 |
| 其他(%) | 5.41 | 1.88 | - | 3.60 | - |
| 毛利构成(%) | |||||
| 药品零售流通(%) | 26.57 | 29.87 | 29.42 | 26.15 | 25.34 |
| 药品生产制造(%) | 69.12 | 69.31 | 70.58 | 77.84 | 74.66 |
| 其他(%) | 4.31 | 0.82 | - | -3.99 | - |